Coastar Therapeutics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 5

Coastar Therapeutics General Information

Description

Developer of a novel drug delivery platform designed to perform repeated virus dosing. The company's platform uses human cell lipids which contain self-identifying motifs, to protect the cancer-destroying virus from being neutralized by neutralizing antibodies and immune cells, enabling medical practitioners to protect the cancer-killing virus from the patient's immune clearance and deliver the payload to the tumor site for cancer-killing and immunotherapy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 9520 Padgett Street
  • Suite101
  • San Diego, CA 92126
  • United States
+1 (858)
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 9520 Padgett Street
  • Suite101
  • San Diego, CA 92126
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Coastar Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator 01-Jan-2025 Completed Pre-Clinical Trials
4. Accelerator/Incubator 10-Oct-2024 Completed Pre-Clinical Trials
3. Later Stage VC 10-Nov-2022 Completed Pre-Clinical Trials
2. Seed Round 30-Jun-2021 $740K $1.24M Completed Pre-Clinical Trials
1. Seed Round 12-Oct-2020 $500K $500K Completed Pre-Clinical Trials
To view Coastar Therapeutics’s complete valuation and funding history, request access »

Coastar Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view Coastar Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Coastar Therapeutics Patents

Coastar Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023028084-A2 Methods and compositions of nucleic acid encapsulated within external membranes Inactive 27-Aug-2021
WO-2023028084-A3 Methods and compositions of nucleic acid encapsulated within external membranes Inactive 27-Aug-2021
AU-2020315645-A1 Process of making membrane lipid coated nanoparticles Pending 16-Jul-2019
EP-3999116-A1 Process of making membrane lipid coated nanoparticles Inactive 16-Jul-2019
EP-3999116-A4 Process of making membrane lipid coated nanoparticles Inactive 16-Jul-2019 C12N7/00
To view Coastar Therapeutics’s complete patent history, request access »

Coastar Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Coastar Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
CONNECT (San Diego) Accelerator/Incubator
Endless Frontier Labs Accelerator/Incubator Minority
Panacea Capital (California) Venture Capital Minority
Proxima Capital Venture Capital Minority
Luminor International Management Venture Capital Minority
To view Coastar Therapeutics’s complete investors history, request access »

Coastar Therapeutics FAQs

  • When was Coastar Therapeutics founded?

    Coastar Therapeutics was founded in 2017.

  • Where is Coastar Therapeutics headquartered?

    Coastar Therapeutics is headquartered in San Diego, CA.

  • What is the size of Coastar Therapeutics?

    Coastar Therapeutics has 8 total employees.

  • What industry is Coastar Therapeutics in?

    Coastar Therapeutics’s primary industry is Drug Delivery.

  • Is Coastar Therapeutics a private or public company?

    Coastar Therapeutics is a Private company.

  • What is Coastar Therapeutics’s current revenue?

    The current revenue for Coastar Therapeutics is .

  • How much funding has Coastar Therapeutics raised over time?

    Coastar Therapeutics has raised $5.24M.

  • Who are Coastar Therapeutics’s investors?

    CONNECT (San Diego), Endless Frontier Labs, Panacea Capital (California), Proxima Capital, and Luminor International Management have invested in Coastar Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process